Monday, July 31, 2017
Man of Steel Issues Voluntary Nationwide Recall of Man of Steel 1 and Man of Steel 2 Due to Tainted Supplements - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2vYzFaQ
via IFTTT
Sunday, July 30, 2017
A Systematic Review and Meta-Analysis of The Effect of Low Vitamin D on Cognition - American Geriatric Society
Background/Objective
With an aging population and no cure for dementia on the horizon, risk factor modification prior to disease onset is an urgent health priority. Therefore, this review examined the effect of low vitamin D status or vitamin D supplementation on cognition in midlife and older adults without a diagnosis of dementia.
Design
Systematic review and random effect meta-analysis.
Setting
Observational (cross-sectional and longitudinal cohort) studies comparing low and high vitamin D status and interventions comparing vitamin D supplementation with a control group were included in the review and meta-analysis.
Participants
Studies including adults and older adults without a dementia diagnosis were included.
Measurements
Medline (PubMed), AMED, Psych INFO, and Cochrane Central databases were searched for articles until August 2016. The Newcastle-Ottawa Scale and Physiotherapy Evidence Database assessed methodological quality of all studies.
Results
Twenty-six observational and three intervention studies (n = 19–9,556) were included in the meta-analysis. Low vitamin D was associated with worse cognitive performance (OR = 1.24, CI = 1.14–1.35) and cognitive decline (OR = 1.26, CI = 1.09–1.23); with cross-sectional yielding a stronger effect compared to longitudinal studies. Vitamin D supplementation showed no significant benefit on cognition compared with control (SMD = 0.21, CI = −0.05 to 0.46).
Conclusion
Observational evidence demonstrates low vitamin D is related to poorer cognition; however, interventional studies are yet to show a clear benefit from vitamin D supplementation. From the evidence to date, there is likely a therapeutic age window relevant to the development of disease and therefore vitamin D therapy. Longitudinal lifespan studies are necessary to depict the optimal timing and duration in which repletion of vitamin D may protect against cognitive decline and dementia in aging, to better inform trials and practice towards a successful therapy.
from Journal of the American Geriatrics Society http://ift.tt/2vX29Ss
via IFTTT
Saturday, July 29, 2017
Vibrant Health Products Issues Allergy Alert On Undeclared Egg In LiveGfree Gluten Free Classic Soft White Hamburger Buns - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2tNeWoX
via IFTTT
Asthma in the Elderly - Geriatrics
from Clinics in Geriatric Medicine http://ift.tt/2uMHm3w
via IFTTT
Friday, July 28, 2017
Accelerometer-Measured Moderate to Vigorous Physical Activity and Incidence Rates of Falls in Older Women - American Geriatric Society
Objectives
To examine whether moderate to vigorous physical activity (MVPA) measured using accelerometry is associated with incident falls and whether associations differ according to physical function or history of falls.
Design
Prospective study with baseline data collection from 2012 to 2014 and 1 year of follow-up.
Setting
Women's Health Initiative participants living in the United States.
Participants
Ambulatory women aged 63 to 99 (N = 5,545).
Measurements
Minutes of MVPA per day measured using an accelerometer, functional status measured using the Short Physical Performance Battery (SPPB), fall risk factors assessed using a questionnaire, fall injuries assessed in a telephone interview, incident falls ascertained from fall calendars.
Results
Incident rate ratios (IRRs) revealed greater fall risk in women in the lowest quartile of MVPA compared to those in the highest (IRR = 1.18, 95% confidence interval = 1.01–1.38), adjusted for age, race and ethnicity, and fall risk factors. Fall rates were not significantly associated with MVPA in women with high SPPB scores (9–12) or one or fewer falls in the previous year, but in women with low SPPB scores (≤ 8) or a history of frequent falls, fall rates were higher in women with lower MVPA levels than in those with higher levels (interaction P < .03 and < .001, respectively). Falls in women with MVPA above the median were less likely to involve injuries requiring medical treatment (9.9%) than falls in women with lower MVPA levels (13.0%) (P < .001).
Conclusion
These findings indicate that falls are not more common or injurious in older women who engage in higher levels of MVPA. These findings support encouraging women to engage in the amounts and types of MVPA that they prefer. Older women with low physical function or frequent falls with low levels of MVPA are a high-risk group for whom vigilance about falls prevention is warranted.
from Journal of the American Geriatrics Society http://ift.tt/2v8iyWb
via IFTTT
ICU Medical Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2v7FhS5
via IFTTT
Bush Brothers & Company® Recalls Certain Baked Beans in 28 Ounce Cans Due to a Can Seam Issue - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2uFjKQb
via IFTTT